ENHANCING STOMACH CARCINOMA STAGING: A COMPREHENSIVE REVIEW OF THE ROLE OF STAGING LAPAROSCOPY AS AN ADJUNCT TO CECT ABDOMEN

Objective: Stomach carcinoma poses challenges in accurate staging and treatment planning. This study explores the evolving role of staging laparoscopy as an adjunct to contrast-enhanced computed tomography (CECT) in enhancing stomach carcinoma staging. Methods: Conducted at Indira Gandhi Medical College and Hospital, Shimla, a one-year prospective study included biopsy-proven gastric carcinoma patients. Exclusion criteria involved neoadjuvant chemotherapy and proven metastasis. Investigations encompassed CECT, staging laparoscopy, and diagnostic lavage. Results: TNM staging revealed a predominance of Stage IIA (21.9%) and IIIA (25%). Locally advanced cases demonstrated infiltration into other organs (53.1%). Occult metastasis was present in 28.2%, with 66.7% in ascites cases. Staging laparoscopy detected occult metastasis in 28.2%, complementing CECT limitations. Significant associations were noted between occult metastasis and CECT staging, particularly in Stage III (88.9%). Conclusion: Integration of staging laparoscopy with CECT enhances precision in stomach carcinoma staging. Limitations of CECT in identifying occult metastasis are addressed by staging laparoscopy, providing valuable insights. Findings underscore the importance of CECT in advanced stages, contributing to comprehensive gastric cancer management. This study contributes to evolving diagnostic and therapeutic approaches, promising improved patient outcomes.